Skip to main content

Advertisement

SpringerLink
Log in

Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To investigate the changes of the serum parathyroid hormone (PTH) and calcium level, as well as bone mineral density (BMD), after percutaneous ultrasound-guided microwave ablation (MWA) for primary hyperparathyroidism (pHPT) caused by single hyperfunctional nodule.

Methods

The study enrolled 20 patients with a total of 20 nodules of MWA treatment to pHPT in one session. The normalization rate of the serum PTH and calcium was evaluated at every 6 months during 2-year follow-up after MWA. The bone mineral density (BMD) at lumbar spine and femoral neck were also compared before and after the procedure.

Results

The normalization rate of both PTH and serum calcium at 6-, 12-, 24-month follow-up was 66.6%, 80.0%, and 62.5%, respectively. Though the normalization rate of serum calcium level at 6-, 12-, and 24-month visit after MWA was 100%. The BMD increased 12, 24 months after MWA at lumbar spine (1.022 ± 0.155, 1.057 ± 0.151 vs 0.965 ± 0.145 g/cm2, p < 0.01) and femoral neck at 2-year assessment (0.819 ± 0.094 vs 0.771 ± 0.102 g/cm2, p = 0.015). Seven nodules disappeared in 20 nodules (35.0%), average ablation time was 122.29 ± 107.54 s (34–460 s). Six patients encountered voice change during the procedure, one participant was confirmed recurrent laryngeal injuries but recovered within 2 months.

Conclusions

Percutaneous ultrasound-guided microwave ablation results in improvement of biochemical profiles and bone mineral density in subjects with single hyperfunctional parathyroid nodule. However, the long-term efficacy of the MWA remains to be verified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. M.W. Yeh, P.H. Ituarte, H.C. Zhou et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98, 1122–1129 (2013)

    Article  CAS  Google Scholar 

  2. R. Udelsman, Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann. Surg. 235, 665–670 (2002)

    Article  Google Scholar 

  3. B. Farford, R.J. Presutti, T.J. Moraghan, Nonsurgical management of primary hyperparathyroidism. Mayo Clin. Proc. 82, 351–355 (2007)

    Article  Google Scholar 

  4. N.A. Hamdy, Parathyroid gland: is parathyroidectomy safe and beneficial in the elderly. Nat. Rev. Endocrinol. 5, 422–423 (2009)

    Article  Google Scholar 

  5. W. Yue, S. Wang, B. Wang et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur. J. Radio. 82, e11–16 (2013)

    Article  Google Scholar 

  6. W. Wu, X. Gong, Q. Zhou, X. Chen, X. Chen, Ultrasound-guided percutaneous microwave ablation for solid benign thyroid nodules: comparison of MWA versus control group. Int J. Endocrinol. 2017, 9724090 (2017)

    PubMed  PubMed Central  Google Scholar 

  7. G. Mauri, L. Cova, C.G. Monaco et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J. Hyperth. 33, 295–299 (2017)

    Article  CAS  Google Scholar 

  8. L. BHH, Oho AUID-, Y.C. Woo, K.W. Chiu, Two-year efficacy of single-session high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules. Eur. Radio. 29, 93–101 (2019)

    Article  Google Scholar 

  9. R. Kovatcheva, J. Vlahov, J. Stoinov, F. Lacoste, C. Ortuno, K. Zaletel, US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur. Radio. 24, 2052–2058 (2014)

    Article  Google Scholar 

  10. J.H. Baek, J.H. Lee, J.Y. Sung et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 262, 335–342 (2012)

    Article  Google Scholar 

  11. Y. Che, S. Jin, C. Shi et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am. J. Neuroradiol. 36, 1321–1325 (2015)

    Article  CAS  Google Scholar 

  12. C. Liu, B. Wu, P. Huang et al. US-guided percutaneous microwave ablation for primary hyperparathyroidism with parathyroid nodules: feasibility and safety study. J. Vasc. Inter. Radio. 27, 867–875 (2016)

    Article  Google Scholar 

  13. B. Fan, X. He, H. Chen, W. Zhang, W. Tang, US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study. Eur. Radio. 29, 5607–5616 (2019)

    Article  Google Scholar 

  14. J.P. Bilezikian, M.L. Brandi, R. Eastell et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3561–3569 (2014)

    Article  CAS  Google Scholar 

  15. M. Ahmed, L. Solbiati, C.L. Brace et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273, 241–260 (2014)

    Article  Google Scholar 

  16. H.M. Ji, J.H. Baek, Y.J. Choi et al. Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules. J. Vasc. Inter. Radio. 26, 55–61 (2015)

    Article  Google Scholar 

  17. Z. Cheng, Y. Che, S. Yu et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci. Rep. 7, 9554 (2017)

    Article  Google Scholar 

  18. E. Hindié, P. Zanotti-Fregonara, A. Tabarin, D. Rubello, I. Morelec, T. Wagner, J.F. Henry, D. Taïeb, The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J. Nucl. Med. 56, 737–744 (2015)

    Article  Google Scholar 

  19. M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14, 115–125 (2018)

    Article  CAS  Google Scholar 

  20. S.Y. Xu, Y. Wang, Q. Xie, H.Y. Wu, Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singap. Med J. 54, e137–e140 (2013)

    Article  Google Scholar 

  21. M. Andrioli, F. Riganti, C.M. Pacella, R. Valcavi, Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. Am. J. Roentgenol. 199, 1164–1168 (2012)

    Article  Google Scholar 

  22. X.L. Cao, Z.G. Cheng, X.L. Yu, Z.Y. Han, P. Liang, Ultrasound-guided percutaneous microwave ablation of parathyroid adenoma. J. Vasc. Inter. Radio. 27, 1929–1931 (2016)

    Article  Google Scholar 

  23. F. Liu, X. Yu, Z. Liu et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J. Hyperth. 36, 835–840 (2019)

    Google Scholar 

  24. J. Hänsler, I.A. Harsch, D. Strobel, E.G. Hahn, D. Becker, [Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA). Ultraschall Med. 23, 202–206 (2002)

    Article  Google Scholar 

  25. D. Lee, M.D. Walker, H.Y. Chen, J.A. Chabot, J.A. Lee, J.H. Kuo, Bone mineral density changes after parathyroidectomy are dependent on biochemical profile. Surgery 165, 107–113 (2019)

    Article  Google Scholar 

  26. G.A. Miguel, F.H. Carranza, R. JCR, M.A. Ramos, D.L. Pablos, E.F. Herrero, G.M. Díaz-Guerra, Trabecular bone score, bone mineral density and bone markers in patients with primary hyperparathyroidism 2 years after parathyroidectomy. Horm. Metab. Res. 51, 186–190 (2019)

    Article  CAS  Google Scholar 

  27. L. Zhao, J.M. Liu, X.Y. He, H.Y. Zhao, L.H. Sun, B. Tao, M.J. Zhang, X. Chen, W.Q. Wang, G. Ning, The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J. Clin. Endocrinol. Metab. 98, 721–728 (2013)

    Article  CAS  Google Scholar 

  28. S. KJL, W. Johnson, M. Yeung, J. Serpell, J.C. Lee, S. Grodski, Surgery for parathyroid microadenomas: patient characteristics, localization success and operative cures. ANZ J. Surg. 88, E21–E24 (2018)

    Article  Google Scholar 

  29. K. Duan, H.K. Gomez, O. Mete, Clinicopathological correlates of hyperparathyroidism. J. Clin. Pathol. 68, 771–787 (2015)

    Article  CAS  Google Scholar 

  30. I. Heo, S. Park, C.W. Jung et al. Fine needle aspiration cytology of parathyroid lesions. Korean J. Pathol. 47, 466–471 (2013)

    Article  Google Scholar 

Download references

Funding

This study was funded by grants from Nature Science Foundation of Zhejiang Province (LY18H030011) and Wenzhou Science and Technology Project (Y20180088, Y20190130).

Author information

Author notes

  1. These authors contributed equally: Wenjun Wu, Qi Zhou

Authors and Affiliations

  1. Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, Zhejiang, China

    Wenjun Wu, Qi Zhou, Feixia Shen, Xiaohua Gong & Xiaojun Chen

  2. Department of Ultrasonography, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, Zhejiang, China

    Shihao Xu

  3. Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, Gansu, China

    Siqin An

  4. Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, Zhejiang, China

    Huanbin Li

Authors
  1. Wenjun Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shihao Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siqin An
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feixia Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huanbin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaohua Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaojun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xiaohua Gong or Xiaojun Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, W., Zhou, Q., Xu, S. et al. Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism. Endocrine 71, 476–483 (2021). https://doi.org/10.1007/s12020-020-02511-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02511-1

Keywords

Search

Navigation